Asian Annals Click here to go to Maquet website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Panangipalli Venugopal
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chauhan, S.
Right arrow Articles by Venugopal, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chauhan, S.
Right arrow Articles by Venugopal, P.
Asian Cardiovasc Thorac Ann 1998;6:270-272
© 1998 Asia Publishing EXchange Pte Ltd


ORIGINAL CONTRIBUTION

Heparin Dosing and Postoperative Blood Loss in Patients Taking Aspirin

Sandeep Chauhan, MD, Tushar Kanti Ghosh, MD, Sushant Srivastava, MCh, Manoj Sahu, MD, Smriti Ranjan Mohanty, MS, Alok Mathur, MS, Nita Saxena, MD, Panangipalli Venugopal, MCh

Department of Cardiothoracic and Vascular Surgery and Department of Cardiac Anaesthesia All India Institute of Medical Sciences New Delhi, India
For reprint information contact: Sandeep Chauhan, MD Department of Cardiac Anaesthesia All India Institute of Medical Sciences Ansari Nagar New Delhi 110029, India Tel: 91 11 66 1123 Ext. 203 Fax:91 11 686 2663
A large number of patients scheduled to undergo elective coronary artery bypass grafting continue to take aspirin along with other antianginal medication up to the day of surgery. Patients taking aspirin preoperatively are known to bleed more in the postoperative period than those not taking aspirin. This study was undertaken to determine whether the method of heparin administration (protocol-based bolus dose versus an individualized dose) affected postoperative blood loss or requirements of blood and blood products in patients taking aspirin preoperatively. In this prospective study, 300 consecutive patients taking aspirin prior to coronary artery bypass graft surgery were randomly assigned to receive heparin either as a protocol-based bolus of 400 IU·kg–1 (group A) or according to a dose-response curve to obtain an activated coagulation time of 500 seconds on cardiopulmonarybypass (group B). Group B required significantly less heparin (mean 275 IU·kg–1)and less protamine than group A. Postoperative blood loss, requirement of blood and blood products, and time spent on hemostasis in group B was significantly less at 24 hours than group A. We concluded that individualized dosing of heparin using a dose-response curve is preferable to a protocol-based bolus heparin dose in patients taking preoperative aspirin.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by the Asia Publishing EXchange Ltd.